The subset of DNA-binding codon mutations accounts for poor overall survival in DLBCL. (A) Overall survival of patients with DNA-binding codon mutations is significantly worse than patients with WT TP53. (B) Overall survival of patients with non–DNA-binding mutations is no different from patients with WT TP53.